NO971743L - Farmasöytisk sammensetning for profylakse og behandling av type I allergiske sykdommer - Google Patents

Farmasöytisk sammensetning for profylakse og behandling av type I allergiske sykdommer

Info

Publication number
NO971743L
NO971743L NO971743A NO971743A NO971743L NO 971743 L NO971743 L NO 971743L NO 971743 A NO971743 A NO 971743A NO 971743 A NO971743 A NO 971743A NO 971743 L NO971743 L NO 971743L
Authority
NO
Norway
Prior art keywords
branched
linear
allergic diseases
type
prophylaxis
Prior art date
Application number
NO971743A
Other languages
English (en)
Other versions
NO971743D0 (no
NO315928B1 (no
Inventor
Yukio Amano
Yuko Mizushima
Kenji Ogata
Original Assignee
Hoechst Japan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Japan filed Critical Hoechst Japan
Publication of NO971743D0 publication Critical patent/NO971743D0/no
Publication of NO971743L publication Critical patent/NO971743L/no
Publication of NO315928B1 publication Critical patent/NO315928B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/655—Azo (—N=N—), diazo (=N2), azoxy (>N—O—N< or N(=O)—N<), azido (—N3) or diazoamino (—N=N—N<) compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO19971743A 1994-10-17 1997-04-16 Anvendelse av en anilidforbindelse for fremstilling av et profylaktisk eller terapeutisk middel for behandling av type I allergiske sykdommer NO315928B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP25029394 1994-10-17
PCT/JP1995/002027 WO1996011682A1 (fr) 1994-10-17 1995-10-04 Composition preventive et remede pour les maladies allergiques de type i

Publications (3)

Publication Number Publication Date
NO971743D0 NO971743D0 (no) 1997-04-16
NO971743L true NO971743L (no) 1997-04-16
NO315928B1 NO315928B1 (no) 2003-11-17

Family

ID=17205757

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19971743A NO315928B1 (no) 1994-10-17 1997-04-16 Anvendelse av en anilidforbindelse for fremstilling av et profylaktisk eller terapeutisk middel for behandling av type I allergiske sykdommer

Country Status (19)

Country Link
US (1) US5814649A (no)
EP (1) EP0787491B1 (no)
KR (1) KR100365064B1 (no)
AT (1) ATE194912T1 (no)
AU (1) AU695907B2 (no)
CA (1) CA2202904C (no)
DE (1) DE69518159T2 (no)
DK (1) DK0787491T3 (no)
ES (1) ES2148561T3 (no)
FI (1) FI971584A0 (no)
GR (1) GR3034413T3 (no)
HU (1) HU222888B1 (no)
IL (1) IL115617A (no)
NO (1) NO315928B1 (no)
NZ (1) NZ293691A (no)
PT (1) PT787491E (no)
TW (1) TW429146B (no)
WO (1) WO1996011682A1 (no)
ZA (1) ZA958708B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE59801792D1 (de) * 1997-08-08 2001-11-22 Aventis Pharma Gmbh Kristallform von N-(4-Trifluormethylphenyl)-5-methylisoxazol-4-carbonsäureamid
EP1057815B1 (en) 1998-02-19 2007-09-05 Kowa Co., Ltd. Cyclic amide compounds
US6303652B1 (en) 1998-08-21 2001-10-16 Hughes Institute BTK inhibitors and methods for their identification and use
US20010026800A1 (en) * 2000-01-07 2001-10-04 Michael Jacob G. Selective activation of a TH1 or TH2 lymphocyte regulated immune response
US6849260B2 (en) 2000-08-18 2005-02-01 Amgen Inc. Methods and compositions for treating IgE-related disease using NNT-1 inhibitors
AU2001236361A1 (en) * 2000-10-20 2002-05-06 Parker Hughes Institute Treatment of asthma with lfm analogues
US6890940B2 (en) 2001-06-29 2005-05-10 Kowa Co., Ltd. Bis(2-aryl-5-pyridyl) derivatives
US6706703B2 (en) 2001-06-29 2004-03-16 Kowa Co., Ltd. Bis(5-aryl-2-pyridyl) derivatives
US8283515B2 (en) 2002-05-03 2012-10-09 Sca Hygiene Products Ab Absorbent article containing a skin conditioning agent
MX336663B (es) 2009-09-18 2016-01-27 Sanofi Sa Formulaciones en comprimido de la (4'-trifluorometilfenil)amida del acido (z)-2-ciano-3-hidroxibut-2-enoico con estabilidad mejorada.

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2854439A1 (de) * 1978-12-16 1980-07-03 Hoechst Ag Ein isoxazolderivat, verfahren zu seiner herstellung, diese verbindung enthaltende mittel und verwendung
DE3534440A1 (de) * 1985-09-27 1987-04-02 Hoechst Ag Arzneimittel gegen chronische graft-versus-host-krankheiten sowie gegen autoimmunerkrankungen, insbesondere systemischen lupus erythematodes
GB8619432D0 (en) * 1986-08-08 1986-09-17 Lilly Industries Ltd Pharmaceutical compounds
DD297328A5 (de) * 1989-08-18 1992-01-09 �������@���������k���Kk�� 5-methyl-isoxalol-4-carbonsaeureanilide und 2 hydroxyethyliden-cyanoessigsaeureanilide zur behandlung von augenerkrankungen
US5001124A (en) * 1990-02-02 1991-03-19 Syntex (U.S.A.) Inc. 4-isoxazolecarboxamide derivatives
DE4127737A1 (de) * 1991-08-22 1993-02-25 Hoechst Ag Arzneimittel zur behandlung von abstossungsreaktionen bei organverpflanzungen
TW314467B (no) * 1993-03-31 1997-09-01 Hoechst Ag

Also Published As

Publication number Publication date
US5814649A (en) 1998-09-29
DK0787491T3 (da) 2000-10-16
IL115617A (en) 1999-11-30
GR3034413T3 (en) 2000-12-29
KR100365064B1 (ko) 2003-04-11
EP0787491A1 (en) 1997-08-06
HUT77135A (hu) 1998-03-02
NO971743D0 (no) 1997-04-16
ZA958708B (en) 1996-05-14
FI971584A (fi) 1997-04-15
DE69518159D1 (de) 2000-08-31
EP0787491A4 (en) 1998-09-30
NZ293691A (en) 1999-07-29
EP0787491B1 (en) 2000-07-26
PT787491E (pt) 2000-11-30
ATE194912T1 (de) 2000-08-15
ES2148561T3 (es) 2000-10-16
AU695907B2 (en) 1998-08-27
CA2202904A1 (en) 1996-04-25
DE69518159T2 (de) 2002-01-03
IL115617A0 (en) 1996-01-19
FI971584A0 (fi) 1997-04-15
WO1996011682A1 (fr) 1996-04-25
CA2202904C (en) 2006-12-19
TW429146B (en) 2001-04-11
HU222888B1 (hu) 2003-12-29
AU3618695A (en) 1996-05-06
KR970706811A (ko) 1997-12-01
NO315928B1 (no) 2003-11-17

Similar Documents

Publication Publication Date Title
GEP20063831B (en) Substituted bicyclic derivatives for treatment of abnormal cell growth
TW430660B (en) Novel benzindole derivatives for neuron cell protection, processes for production, and the pharmaceutical compounds containing them
UY25679A1 (es) Derivados de quinolin-2-ona inhibidores de la farnesil proteína transferasa útiles como agentes contra el cáncer
ATE375341T1 (de) Thiadiazolylpiperazinderivate geeignet für die behandlung bzw. prävention von schmerzen
FI950309A (fi) Proliiniamidijohdannaisia
NO971743L (no) Farmasöytisk sammensetning for profylakse og behandling av type I allergiske sykdommer
ATE366107T1 (de) Verwendung von sulfodehydroabietinsäure zur behandlung entzündlicher darmerkrankungen
DE69917074D1 (de) Optisch aktives pyridyl-4h-1,2,4-oxadiazinderivat und seine verwendung zur behandlung von gefässkrankheiten
DE69828197D1 (de) Amidderivate zur behandlung neurodegenerativer erkrankungen der netzhaut
AU7424394A (en) 3- or 4-glycosyloxybenzopyran derivatives and antiallergic agents containing the derivatives as active ingredients
ATE352317T1 (de) Therapeutische behandlung von eosinophilie durch verwendung von chymase-inhibitoren als aktiven bestandteilen
DE69619088T2 (de) Quinoxalin-Derivate zur Behandlung von Tinnitus
ATE247903T1 (de) Fungizide zusammensetzung enthaltend ein n- benzoyl-n&#39;-phenyl-harnstoff derivat
DE69910706D1 (de) Medikament zur Behandlung von Glaukoma und ischämischer Retinopathie
NO20004679L (no) Farmasøytisk sammensetning inneholdende en cystein- proteasehemmer for forebygging og terapi av hjernevevsforringelse
NO941478D0 (no) Ny forbindelse, Leustroducsin H, dens fremstilling og dens terapeutiske anvendelse
ATE223418T1 (de) 4&#39;-substituierte-4&#39;,5&#39;-dihydropsoralene und deren therapeutische verwendung